New Technology Simplifies Fluid Management for Hysteroscopic Procedures
By HospiMedica International staff writers Posted on 29 Aug 2018 |
Image: The Fluent fluid management system (Photo courtesy of Hologic).
A novel management system provides operating room (OR) staff a more simplified and effective method for fluid control during hysteroscopic procedures.
The Hologic (Bedford, MA, USA) Fluent fluid management system is designed to both provide liquid distension of the uterus during diagnostic and operative hysteroscopy, and to monitor the volume differential between the irrigation fluid flowing into and out of the uterus while providing drive, control, and suction for hysteroscopic morcellators and a wide variety of other hysteroscopic devices. To simplify the surgical procedures, a single waste bag and unique FloPak technology are used to effectively control fluid use throughout the procedure.
An intuitive user interface helps optimize the operating room (OR) workflow, and also provides step-by-step instructions for setup, disassembly, and troubleshooting of the system. In addition, large visual and audible alerts monitor fluid deficit, pressure, low fluid bags, and full waste bags to help keep procedures moving as efficiently as possible. The system also has the ability to detect accurate fluid deficit within 50 mL. When running together with the proprietary MyoSure system, the Fluent system shows a change in average intrauterine pressure of less than one percent.
“Fluid management plays a vital role in gynecological procedures, yet there have been few advances in the technology,” said Edward Evantash, MD, medical director and vice president of global medical affairs at Hologic. “The Fluent system is changing the game in fluid management. Developed in response to the challenges facing nurses and doctors performing hysteroscopies, it combines a streamlined design with innovative technology for more efficient fluid monitoring during procedures.”
Morcellation involves minimally invasive surgical (MIS) fragmentation of the uterus into smaller pieces so as to facilitate its removal during hysteroscopic procedures. In May 2014, the U.S. Food and Drug Administration (FDA) issued a warning against using laparoscopic power morcellator devices in MIS to remove uterine fibroids, claiming that women undergoing the procedures carry a 1 in 350 risk of uterine sarcoma, and that morcellator tools could worsen the spread of cancerous tissue.
The Hologic (Bedford, MA, USA) Fluent fluid management system is designed to both provide liquid distension of the uterus during diagnostic and operative hysteroscopy, and to monitor the volume differential between the irrigation fluid flowing into and out of the uterus while providing drive, control, and suction for hysteroscopic morcellators and a wide variety of other hysteroscopic devices. To simplify the surgical procedures, a single waste bag and unique FloPak technology are used to effectively control fluid use throughout the procedure.
An intuitive user interface helps optimize the operating room (OR) workflow, and also provides step-by-step instructions for setup, disassembly, and troubleshooting of the system. In addition, large visual and audible alerts monitor fluid deficit, pressure, low fluid bags, and full waste bags to help keep procedures moving as efficiently as possible. The system also has the ability to detect accurate fluid deficit within 50 mL. When running together with the proprietary MyoSure system, the Fluent system shows a change in average intrauterine pressure of less than one percent.
“Fluid management plays a vital role in gynecological procedures, yet there have been few advances in the technology,” said Edward Evantash, MD, medical director and vice president of global medical affairs at Hologic. “The Fluent system is changing the game in fluid management. Developed in response to the challenges facing nurses and doctors performing hysteroscopies, it combines a streamlined design with innovative technology for more efficient fluid monitoring during procedures.”
Morcellation involves minimally invasive surgical (MIS) fragmentation of the uterus into smaller pieces so as to facilitate its removal during hysteroscopic procedures. In May 2014, the U.S. Food and Drug Administration (FDA) issued a warning against using laparoscopic power morcellator devices in MIS to remove uterine fibroids, claiming that women undergoing the procedures carry a 1 in 350 risk of uterine sarcoma, and that morcellator tools could worsen the spread of cancerous tissue.
Latest Surgical Techniques News
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery
- Robotic Nerve ‘Cuffs’ Could Treat Various Neurological Conditions
- Flexible Microdisplay Visualizes Brain Activity in Real-Time To Guide Neurosurgeons
- Next-Gen Computer Assisted Vacuum Thrombectomy Technology Rapidly Removes Blood Clots
- Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices
- Custom 3D-Printed Orthopedic Implants Transform Joint Replacement Surgery
- Wearable Technology Monitors and Analyzes Surgeons' Posture during Long Surgical Procedures
- Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery
- Computational Models Predict Heart Valve Leakage in Children
- Breakthrough Device Enables Clear and Real-Time Visual Guidance for Effective Cardiovascular Interventions
- World’s First Microscopic Probe to Revolutionize Early Cancer Diagnosis
- World’s Smallest Implantable Brain Stimulator Demonstrated in Human Patient
- Robotically Assisted Lung Transplants Could Soon Become a Reality
- AI to Provide Heart Transplant Surgeons with New Decision-Making Data
- New Surgical Tool Empowers Precision and Confidence in Operating Room